Seeing Is Believing
Currently out of the existing stock ratings of Steven Seedhouse, 241 are a BUY (93.77%), 15 are a HOLD (5.84%), 1 are a SELL (0.39%).
Analyst Steven Seedhouse works at RAYMOND JAMES with a stock forecast success ratio of 37.71% fulfilled within 295.13 days on average.
Steven Seedhouse’s has documented 456 price targets and ratings displayed on 32 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on VKTX, Viking Therapeutics at 27-Feb-2024.
Analyst best performing recommendations are on VERA (VERA THERAPEUTICS).
The best stock recommendation documented was for NGM (NGM BIOPHARMACEUTICALS) at 10/17/2022. The price target of $4 was fulfilled within 3 days with a profit of $0.59 (17.3%) receiving and performance score of 57.67.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
205
$22.5 (12.33%)
3 years ago
3/5 (60%)
$35.09 (20.65%)
938
Hold
173
$-9.5 (-5.21%)
156
3 years 2 days ago
14/24 (58.33%)
$2.73 (1.60%)
682
Hold
190
$7.5 (4.11%)
194
3 years 3 months 1 days ago
9/11 (81.82%)
$34.41 (22.12%)
350
Hold
166
$-16.5 (-9.04%)
175
3 years 3 months 1 days ago
23/23 (100%)
$10.41 (6.69%)
828
Buy
155
3 years 3 months 28 days ago
7/7 (100%)
$36.79 (31.12%)
395
Which stock is Steven Seedhouse is most bullish on?
Which stock is Steven Seedhouse is most reserved on?
What Year was the first public recommendation made by Steven Seedhouse?